PolyPid to Present at Upcoming Healthcare Investor Conferences

PETAH TIKVA, Israel , June 02, 2021 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD ), a late-stage biopharma company aiming to improve surgical outcomes through locally administered, controlled, extended-release therapeutics, today announced that members of its executive management team will